Live(r) with a Fontan circulation: A European survey and a proposed expert consensus on liver surveillance in collaboration with the EuroFontan group

  • Claudia Montanaro
  • , Pietro Paolo Tamborrino*
  • , Suman Verma
  • , Gianfranco Butera
  • , Konstantinos Dimopoulos
  • , Magalie Ladouceur
  • , Gruschen Veldtman
  • , Francesca Baessato
  • , Alvaro Gonzalez Rocafort
  • , Inés Ponz de Antonio
  • , Bejal Pandja
  • , Alessandra Frigiola
  • , Giulia Iannaccone
  • , Polona Kacar
  • , Kate English
  • , Katja Prokselj
  • , Michael Carbonell
  • , Alexander van de Bruaene
  • , George Giannakoulas
  • , Petra Jenkins
  • Georges Sarris*, Andrzej Kansy, Jolien W. Roos-Hesselink, Audrey Payance, Montserrat Fraga, Judith Bouchardy, Inga Voges, Oktay Tutarel, Caroline Ovaert, Zakaria Jalal, Liliana Chemello, Massimo A. Padalino, Giovanni Tritto, Michael A. Gatzoulis
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: 

A widely accepted protocol for the diagnosis and follow-up of Fontan Associated Liver Disease (FALD) is currently lacking, thus we undertook a European survey with the dual aim of examining the current status quo and developing a shared screening algorithm. 

Methods:

In this cross-sectional qualitative study, 39 Adult Congenital Heart Disease (ACHD) centres in Europe were invited (between August 2023 and April 2024) to participate in a survey regarding their approach to FALD diagnosis and surveillance. 

Results:

Twenty-two (54.5 %) centres from 11 Countries responded to the survey. Patients with a Fontan circulation had annual liver assessment in the majority of centres, with review of selected case by a specialist hepatologist. Different scoring systems were employed to quantify the severity of FALD (Child-Pugh score, MELD XI, FIB4). Ultrasound was the first-line imaging modality, followed by magnetic resonance imaging and computed tomography. Liver fibrosis and portal hypertension were assessed with different modalities and at variable time intervals ranging from 1 to 3 years, with the most used technique being the Fibroscan (74 %). Half of the centres would consider transplant referral in the presence of FALD. Combined heart-liver transplantation was an option in 8 centres. 

Conclusions: 

Our data suggests universal agreement amongst European ACHD centres on the need for regular assessment of adult patients for FALD, often with the involvement of a hepatologist, though the approaches varied widely between centres. We propose herewith a FALD surveillance algorithm to introduce a uniform approach to this complex entity which impacts on the growing number of patients with a Fontan circulation.

Original languageEnglish
Article number134118
JournalInternational Journal of Cardiology
Volume447
DOIs
Publication statusPublished - 15 Mar 2026

Bibliographical note

Publisher Copyright:
© 2025

Fingerprint

Dive into the research topics of 'Live(r) with a Fontan circulation: A European survey and a proposed expert consensus on liver surveillance in collaboration with the EuroFontan group'. Together they form a unique fingerprint.

Cite this